Full Professor(heuristic)

Epigenetics and DNA Methylation · Molecular Biology

Compare more Molecular Biology professors.

h-index141
i10-index367
Publications929
Citations109,666

Grants

8 total · 2 active

NIH #I01CX002801

Biomarker Directed trial of Temozolomide and PARP inhibition in relapsed SCLC

Active
Amount
—
Period
2025-07-01 → 2030-06-30
PIs
2

Awarded at RLR VA MEDICAL CENTER

NIH #U2CCA271885

Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies

Active
Amount
$800K–$900K
Period
2022-09-16 → 2027-08-31
PIs
3

Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH

NIH #P30CA047904

Cancer Epidemiology and Prevention Program

Amount
<$100K
Period
1997-09-10 → 2025-07-31
PIs
1

Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

8 total · 2 active

NIH #I01CX002801

Biomarker Directed trial of Temozolomide and PARP inhibition in relapsed SCLC

Active
Amount
—
Period
2025-07-01 → 2030-06-30
PIs
2

Awarded at RLR VA MEDICAL CENTER

NIH #U2CCA271885

Optimizing Ultrasensitive DNA methylation detection for lung cancer and other malignancies

Active
Amount
$800K–$900K
Period
2022-09-16 → 2027-08-31
PIs
3

Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH

NIH #P30CA047904

Cancer Epidemiology and Prevention Program

Amount
<$100K
Period
1997-09-10 → 2025-07-31
PIs
1

Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH

NIH #U01CA214165

Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung Cancer 

Amount
$500K–$600K
Period
2016-09-15 → 2021-08-31
PIs
2

Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH

NIH #P50CA090440

SPORE in Lung Cancer

Amount
$2M–$3M
Period
2001-06-01 → 2017-08-31
PIs
1

Awarded at UNIVERSITY OF PITTSBURGH AT PITTSBURGH

NIH #P50CA058184

P1: Epigenetic Staging and Therapy for Lung Cancers

Amount
$400K–$500K
Period
2008-10-01 → 2013-09-30
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #R33CA127055

CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer

Amount
$200K–$300K
Period
2008-08-01 → 2012-07-31
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #R21CA127055

CHFR Methylation for Predicting Taxane Sensitivity in Lung and Esophageal Cancer

Amount
$200K–$300K
Period
2007-07-01 → 2009-06-30
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

Recent Public Signals

  1. New paper: Table S1 from Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer2026-07-01
  2. New preprint: The Vanguard Study: Assessing feasibility of conducting randomized trials of novel multi-cancer detection testsShort title: The Vanguard Study: Assessing feasibility of randomized multi-cancer detection clinical trials2026-01-01
  3. New NIH award: Biomarker Directed trial of Temozolomide and PARP inhibition in relapsed SCLC2025-07-01

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0001-8102-1740

Professor Insights

Career Trajectory